Combination of chemotherapeutic agents and biological response modifiers (immunotherapy) in triple-negative/Her2( +) breast cancer, multiple myeloma, and non-small-cell lung cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2589-0409
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Combination of chemotherapeutic agents and biological response modifiers (immunotherapy) in triple-negative/Her2( +) breast cancer, multiple myeloma, and non-small-cell lung cancer ; volume:34 ; number:1 ; day:2 ; month:1 ; year:2023 ; pages:1-12 ; date:12.2022
Journal of the Egyptian National Cancer Institute / Egyptian National Cancer Institute; 34, Heft 1 (2.1.2023), 1-12, 12.2022
- Creator
-
Morse, William
Nawaz, Haroon
Choudhry, Ayesha A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s43046-022-00159-8
- URN
-
urn:nbn:de:101:1-2023022421022354024815
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Morse, William
- Nawaz, Haroon
- Choudhry, Ayesha A.
- SpringerLink (Online service)
Other Objects (12)
The Effect of Chemotherapeutic Agents on Survival in Metastatic Non-Small-Cell Lung Cancer with KRAS Mutation
Urologic cancer : chemotherapeutic principles and management
Non-small-cell lung cancer
Altering phosphorylation in cancer through PP2A modifiers
Direct Immunoactivation by Chemotherapeutic Drugs in Cancer Treatment
Crotonylated BEX2 interacts with NDP52 and enhances mitophagy to modulate chemotherapeutic agent-induced apoptosis in non-small-cell lung cancer cells
Chemotherapeutic treatment of colorectal cancer in pregnancy: case report
Pharmacometric applications in non-small-cell lung cancer
Wnt Lipidation and Modifiers in Intestinal Carcinogenesis and Cancer
Oncogenic HER2 fusions in gastric cancer
Is HER2 ultra-low breast cancer different from HER2 null or HER2 low breast cancer? A study of 1363 patients
Stromal and epithelial mechanisms of chemotherapeutic resistance in pancreatic cancer
The Effect of Chemotherapeutic Agents on Survival in Metastatic Non-Small-Cell Lung Cancer with KRAS Mutation
Urologic cancer : chemotherapeutic principles and management
Non-small-cell lung cancer
Altering phosphorylation in cancer through PP2A modifiers
Direct Immunoactivation by Chemotherapeutic Drugs in Cancer Treatment
Crotonylated BEX2 interacts with NDP52 and enhances mitophagy to modulate chemotherapeutic agent-induced apoptosis in non-small-cell lung cancer cells
Chemotherapeutic treatment of colorectal cancer in pregnancy: case report
Pharmacometric applications in non-small-cell lung cancer
Wnt Lipidation and Modifiers in Intestinal Carcinogenesis and Cancer
Oncogenic HER2 fusions in gastric cancer
Is HER2 ultra-low breast cancer different from HER2 null or HER2 low breast cancer? A study of 1363 patients
Stromal and epithelial mechanisms of chemotherapeutic resistance in pancreatic cancer
The Effect of Chemotherapeutic Agents on Survival in Metastatic Non-Small-Cell Lung Cancer with KRAS Mutation
Urologic cancer : chemotherapeutic principles and management
Non-small-cell lung cancer
Altering phosphorylation in cancer through PP2A modifiers
Direct Immunoactivation by Chemotherapeutic Drugs in Cancer Treatment
Crotonylated BEX2 interacts with NDP52 and enhances mitophagy to modulate chemotherapeutic agent-induced apoptosis in non-small-cell lung cancer cells
Chemotherapeutic treatment of colorectal cancer in pregnancy: case report
Pharmacometric applications in non-small-cell lung cancer
Wnt Lipidation and Modifiers in Intestinal Carcinogenesis and Cancer
Oncogenic HER2 fusions in gastric cancer
Is HER2 ultra-low breast cancer different from HER2 null or HER2 low breast cancer? A study of 1363 patients